January 27, 2014
Accenture Positioned as a Leader in IDC MarketScape Worldwide Life Sciences Sales & Marketing Strategic Consulting Vendor Assessment
NEW YORK; Jan. 27, 2014 – Accenture (NYSE:ACN) has been positioned as a Leader in an IDC Health Insights vendor assessment covering strategic consulting across the life sciences sales & marketing strategic consulting industry.
The report, “IDC MarketScape: Worldwide Life Science Sales and Marketing Strategic Consulting 2013 Vendor Assessment (#HI244309),” provides an assessment of the life science strategic consulting industry and market trends, comparing major vendors and assesses the criteria that are most important for life science companies to consider when selecting a service provider.
For the purposes of this analysis, IDC divided potential key measures for success into two primary categories: capabilities and strategies. The assessment includes client references. IDC Health Insights evaluated 15 vendors for this assessment.
“We are proud to be recognized as a Leader in this IDC MarketScape vendor assessment on Strategic Consulting. This is a testament to the depth of our industry knowledge and the work we do every day with our clients around the world to build and operate new commercial models,” said Anne O’Riordan, global senior managing director, Accenture Life Sciences. “These are exciting times for life science sales and marketing organizations as the era of scientific marketing unfolds. Companies focused on the core science in their products - combined with analytic driven targeting and multichannel conversations - are driving a new wave of value and improved outcomes for patients and payers.”
In naming Accenture as a Leader, the IDC MarketScape stated, “Relative to other vendors discussed in this report, and based on feedback from multiple customer references, Accenture received extremely high marks in project management and life science industry expertise.”
|Source: IDC Health Insights, 2013
The IDC MarketScape Capabilities score measures vendor product, go-to-market and business execution in the short-term. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles. Vendor year-over-year growth rate relative to the given market is indicated by a plus, neutral or minus next to the vendor name.
Click here to learn more about Accenture’s Life Sciences practice.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of IT, telecommunications, or industry-specific suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT, telecommunications, or industry-specific vendors can be meaningfully compared. The framework also provides technology buyers with a transparent foundation to allow companies to independently compare the strengths and weaknesses of current and prospective vendors.
Accenture is a global management consulting, technology services and outsourcing company, with approximately 281,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013. Its home page is www.accenture.com.
# # #